amifloxacin has been researched along with ciprofloxacin in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 38 (77.55) | 18.7374 |
1990's | 7 (14.29) | 18.2507 |
2000's | 3 (6.12) | 29.6817 |
2010's | 1 (2.04) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koga, H; Ohta, M | 1 |
Domagala, JM; Heifetz, CL; Hutt, MP; Mich, TF; Nichols, JB; Solomon, M; Worth, DF | 1 |
Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M | 1 |
Domagala, JM; Heifetz, CL; Mich, TF; Nichols, JB | 1 |
Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT | 1 |
Baroni, M; Cecchetti, V; Cianchetta, G; Cruciani, G; Mannhold, R | 1 |
Jolivette, LJ; Ward, KW | 1 |
Brown, RR; Cook, JA; Crawmer, BP | 1 |
Boyko, EJ; Iravani, A; Schelling, DJ; Silverman, MH; Wright, RA | 1 |
Hung, CT; Lam, F; Nangia, A | 1 |
Boddy, AW; Brown, RR; Cook, JA; Sauerschell, R; Silverman, MH; Stroshane, RM | 1 |
Brown, RR; Cook, JA; Nix, DE; Schelling, DJ; Schentag, JJ; Silverman, MH; Stroshane, RM | 1 |
Lentino, JR; Strodthman, R | 1 |
Inoue, M; Mitsuhashi, S; Watanabe, M | 1 |
Prymas, LA; Shayegani, A; Venezia, RA; Yocum, DM | 1 |
Bia, FJ; Divo, AA; Patton, CL; Sartorelli, AC | 1 |
Smith, SM | 1 |
Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL | 2 |
Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH | 1 |
Baltch, AL; Bassey, CM; Smith, RP | 1 |
Høiby, N | 1 |
Diana, GD; McKinlay, MA; Otto, MJ | 1 |
Alderman, HC; Alvarez, ME; Bodey, GP; Ho, DH; Hoy, JF; Rolston, KV | 1 |
Digranes, A | 1 |
Habiyaremye, I; Vandepitte, J; Verbist, L | 1 |
Pattyn, SR; Van Caekenberghe, DL; Verhoeven, JR | 1 |
Clark, JK; Manzella, JP | 1 |
Fallon, RJ | 1 |
Alvarez, ME; Bodey, GP; Hsu, KC; Rolston, KV | 1 |
Appelbaum, PC; Sollenberger, L; Spangler, SK | 1 |
Barry, AL; Jones, RN | 1 |
Dørflinger, T; Gasser, TC; Graversen, PH; Larsen, EH | 1 |
DiVincenzo, C; Foster, JK; Lentino, JR; Strodtman, R | 1 |
Bailey, DM; Cornett, JB; Dobson, RA; Wagner, RB; Wentland, MP | 1 |
Iravani, A; Newton, BR; Richard, GA; Welty, GS | 1 |
Dørflinger, T; Frimodt-Møller, PC; Madsen, PO | 1 |
Benziger, DP; Crawmer, BP; McCoy, LF | 1 |
Benziger, DP; Johnson, JA | 1 |
Labthavikul, P; Neu, HC | 1 |
Cornett, J; Freeman, S; Wormuth, J | 1 |
Pohlod, DJ; Saravolatz, LD | 1 |
O'Keefe, JP; Tatarowicz, WA; Thompson, KD | 1 |
John, JF; Twitty, JA | 1 |
Baltch, AL; Conley, PE; Smith, RP; Sutphen, NT | 1 |
Barza, M; Jacobus, NV; Tally, FP | 1 |
Bodey, GP; Fainstein, V; Garcia, I; Ho, DH; LeBlanc, B | 1 |
Muszynski, MJ; Rajyaguru, JM | 1 |
Li, Y; Wang, X; Zhao, X | 1 |
1 review(s) available for amifloxacin and ciprofloxacin
Article | Year |
---|---|
Inhibitors of picornavirus uncoating as antiviral agents.
Topics: Animals; Anti-Infective Agents; Antiviral Agents; Chalcone; Chalcones; Ciprofloxacin; Flavonoids; Fluoroquinolones; Furans; Humans; Isoxazoles; Ketones; Picornaviridae; Picornaviridae Infections; Quinolines; Rhinovirus; Structure-Activity Relationship | 1985 |
2 trial(s) available for amifloxacin and ciprofloxacin
Article | Year |
---|---|
Randomized, controlled trial of a 10-day course of amifloxacin versus trimethoprim-sulfamethoxazole in the treatment of acute, uncomplicated urinary tract infection. Amifloxacin Multi-Center Trial Group.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1990 |
Multiple-dose pharmacokinetics and safety of oral amifloxacin in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Fluoroquinolones; Humans; Male; Middle Aged; Reference Values | 1990 |
46 other study(ies) available for amifloxacin and ciprofloxacin
Article | Year |
---|---|
Three-dimensional structure-activity relationships and receptor mapping of N1-substituents of quinolone antibacterials.
Topics: 4-Quinolones; Anti-Infective Agents; Computer Simulation; Escherichia coli; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Molecular Structure; Receptors, Drug; Software; Structure-Activity Relationship | 1991 |
1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Carboxylic Acids; Chemical Phenomena; Chemistry; Mice; Microbial Sensitivity Tests; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1988 |
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones | 2003 |
Chemometric studies on the bactericidal activity of quinolones via an extended VolSurf approach.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Escherichia coli; Models, Molecular; Pseudomonas aeruginosa; Quantitative Structure-Activity Relationship; Quinolones; Staphylococcus aureus; Thermodynamics | 2004 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Determination of amifloxacin and two of its principal metabolites in plasma and urine by high-performance liquid chromatography using automated column switching.
Topics: Animals; Anti-Infective Agents; Autoanalysis; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Ciprofloxacin; Dogs; Fluoroquinolones; Haplorhini; Humans; Indicators and Reagents; Male; Rats; Reference Standards | 1990 |
Reversed-phase ion-pair high-performance liquid chromatographic determination of fluoroquinolones in human plasma.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Indicators and Reagents; Male; Regression Analysis | 1990 |
Preliminary study of the pharmacokinetics of oral amifloxacin in elderly subjects.
Topics: Adult; Aged; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Female; Fluoroquinolones; Humans; Male; Spectrophotometry, Ultraviolet | 1990 |
Comparison of in vitro activity of daptomycin, vancomycin and fluoroquinolones in broth and serum against Staphylococcus epidermidis as determined by time-kill kinetics.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Daptomycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Peptides; Staphylococcus epidermidis; Vancomycin | 1989 |
In vitro activity of amifloxacin against outer membrane mutants of the family Enterobacteriaceae and frequency of spontaneous resistance.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Salmonella typhimurium; Topoisomerase II Inhibitors | 1989 |
In vitro activities of amifloxacin and two of its metabolites.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1989 |
Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
Topics: Aminocoumarins; Animals; Anti-Infective Agents; Chloroquine; Ciprofloxacin; Coumarins; Drug Interactions; Drug Resistance; Enoxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Oxolinic Acid; Pefloxacin; Plasmodium falciparum; Tetracycline; Topoisomerase II Inhibitors | 1988 |
In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Methicillin; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Piperazines; Quinolines; Staphylococcus aureus | 1986 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica | 1985 |
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae | 1985 |
Comparative in vitro studies with 4-quinolone antimicrobials.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1985 |
Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines | 1986 |
Clinical uses of nalidixic acid analogues: the fluoroquinolones.
Topics: Administration, Oral; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Male; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Topoisomerase II Inhibitors | 1986 |
In-vitro activity of Sch 34343, a new penam, against gram-positive isolates from cancer patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Listeria monocytogenes; Neoplasms; Staphylococcus; Streptococcus; Thienamycins | 1986 |
In vitro activity of amifloxacin (WIN 49,375) compared with those of ciprofloxacin and ofloxacin.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ofloxacin; Oxazines; Pseudomonas | 1987 |
[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Topics: Anti-Bacterial Agents; Campylobacter fetus; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Salmonella; Shigella; Vibrio cholerae; Yersinia enterocolitica | 1987 |
In vitro activity of five new quinolones against cultivable mycobacteria.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin | 1987 |
Effects of quinolones on mitogen-stimulated human mononuclear leucocytes.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; In Vitro Techniques; Lymphocyte Activation; Norfloxacin; Phytohemagglutinins; Quinolines; Quinolones | 1988 |
In-vitro sensitivity of legionellas and mycoplasmas to amifloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Legionella; Microbial Sensitivity Tests; Mycoplasma | 1988 |
In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients.
Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Ciprofloxacin; Cross Infection; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Quinolines; Thienamycins | 1986 |
Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and cefpirome.
Topics: Anti-Infective Agents; Cefpirome; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolines | 1986 |
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines | 1987 |
Quinolone penetration into canine vaginal and urethral secretions.
Topics: Animals; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Dogs; Enoxacin; Female; Fluoroquinolones; Mucous Membrane; Naphthyridines; Norfloxacin; Quinolines; Urethra; Vagina | 1987 |
Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Gentamicins; Kinetics; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Staphylococcus aureus; Vancomycin | 1986 |
In vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin).
Topics: Animals; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Quinolines | 1985 |
Effects of changes in pH, medium, and inoculum size on the in vitro activity of amifloxacin against urinary isolates of Staphylococcus saprophyticus and Escherichia coli.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Culture Media; Escherichia coli; Fluoroquinolones; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Quinolines; Staphylococcus | 1985 |
Amifloxacin distribution in the dog prostate.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dogs; Fluoroquinolones; Male; Prostate; Quinolines; Tissue Distribution | 1985 |
Analysis of amifloxacin in plasma and urine by high-pressure liquid chromatography and intravenous pharmacokinetics in rhesus monkeys.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Female; Fluoroquinolones; Half-Life; Injections, Intravenous; Kinetics; Macaca mulatta; Quinolines | 1985 |
Metabolism and disposition of amifloxacin in laboratory animals.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biotransformation; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Ciprofloxacin; Feces; Female; Fluoroquinolones; Macaca mulatta; Male; Mass Spectrometry; Quinolines; Rats; Rats, Inbred Strains; Tissue Distribution | 1985 |
Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolines; Species Specificity | 1985 |
In vitro activity of amifloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
Topics: Anti-Infective Agents; Chlamydia trachomatis; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Quinolines; Ureaplasma | 1985 |
In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas; Quinolines; Staphylococcus; Tobramycin | 1984 |
In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside-resistant Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolines | 1984 |
Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Enterobacter; Escherichia coli; Fluoroquinolones; Gentamicins; Gram-Negative Bacteria; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolines | 1984 |
Inhibitory and bactericidal activities of amifloxacin, a new quinolone carboxylic acid, compared with those of seven other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Culture Media; Fluoroquinolones; Gram-Negative Bacteria; Lactams; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quinolines | 1984 |
Antimicrobial spectrum of Win 49375.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Ciprofloxacin; Culture Media; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Quinolines | 1984 |
In vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neoplasms; Quinolines | 1984 |
Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds.
Topics: 1-Naphthylamine; Anti-Infective Agents; Azithromycin; Bacterial Outer Membrane Proteins; Burkholderia cepacia; Cations; Ceftazidime; Cell Membrane Permeability; Ciprofloxacin; Clarithromycin; Fleroxacin; Fluorescent Dyes; Fluoroquinolones; Gentamicins; Magnesium; Microbial Sensitivity Tests; Microscopy, Electron; Novobiocin; Oxolinic Acid; Polysaccharides, Bacterial; Tobramycin | 1997 |
Combined HQSAR method and molecular docking study on genotoxicity mechanism of quinolones with higher genotoxicity.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Damage; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Docking Simulation; Quantitative Structure-Activity Relationship; Quinolones; Structure-Activity Relationship | 2019 |